# An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face

> **NCT07729579** · PHASE1 · RECRUITING · sponsor: **Sun Pharmaceutical Industries Limited** · enrollment: 48 (estimated)

## Conditions studied

- Actinic Keratosis (AK)

## Interventions

- **DRUG:** Investigational drug
- **DEVICE:** Photodynamic therapy

## Key facts

- **NCT ID:** NCT07729579
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-04
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07729579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07729579, "An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07729579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*